当前位置:首页 - 行情中心 - 之江生物(688317) - 财务分析 - 现金流量表

之江生物

(688317)

  

流通市值:32.90亿  总市值:32.90亿
流通股本:1.92亿   总股本:1.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金30,131,909.48159,107,518.57120,213,144.2280,671,108.63
  收到的税费返还56,112.4830,093,967.9--
  收到其他与经营活动有关的现金10,863,778.2369,655,823.5251,878,128.1343,534,920
  经营活动现金流入小计41,051,800.19258,857,309.99172,091,272.35124,206,028.63
  购买商品、接受劳务支付的现金3,351,833.9829,720,255.7817,018,580.4810,449,478.02
  支付给职工以及为职工支付的现金21,885,869.8174,016,837.2357,114,359.5140,242,703.61
  支付的各项税费5,309,364.3717,916,785.5413,908,036.039,796,648
  支付其他与经营活动有关的现金14,164,472.9470,349,999.7351,377,879.6637,892,891.4
  经营活动现金流出小计44,711,541.1192,003,878.28139,418,855.6898,381,721.03
  经营活动产生的现金流量净额-3,659,740.9166,853,431.7132,672,416.6725,824,307.6
二、投资活动产生的现金流量:
  收回投资收到的现金263,513,630.781,117,230,829.5694,998,538.3284,689,173.15
  处置固定资产、无形资产和其他长期资产收回的现金净额-626,093.48340,0000
  投资活动现金流入小计263,513,630.781,117,856,922.98695,338,538.3284,689,173.15
  购建固定资产、无形资产和其他长期资产支付的现金22,378,976.91,994,776.173,068,392.52,974,379.5
  投资支付的现金330,165,2941,422,586,455.161,011,507,951.71597,598,133.5
  投资活动现金流出小计352,544,270.91,424,581,231.331,014,576,344.21600,572,513
  投资活动产生的现金流量净额-89,030,640.12-306,724,308.35-319,237,805.91-315,883,339.85
三、筹资活动产生的现金流量:
  取得借款收到的现金-297,000,000198,000,000198,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-297,000,000198,000,000198,000,000
  偿还债务支付的现金1,980,0002,980,0001,980,000-
  分配股利、利润或偿付利息支付的现金1,368,1013,032,195.551,840,803.25875,737.5
  支付其他与筹资活动有关的现金18,882,804.94261,344,830.68221,026,950.57182,926,350.18
  筹资活动现金流出小计22,230,905.94267,357,026.23224,847,753.82183,802,087.68
  筹资活动产生的现金流量净额-22,230,905.9429,642,973.77-26,847,753.8214,197,912.32
四、汇率变动对现金及现金等价物的影响-15,069,979.84-23,008,255.17-9,676,055.88-2,373,500.83
五、现金及现金等价物净增加额-129,991,266.81-233,236,158.04-323,089,198.94-278,234,620.76
  加:期初现金及现金等价物余额2,552,732,482.862,783,176,213.262,783,392,638.522,783,176,213.26
  期末现金及现金等价物余额2,422,741,216.052,549,940,055.222,460,303,439.582,504,941,592.5
补充资料:
  净利润--34,297,566.55--9,850,972.77
  资产减值准备--10,775,110.55--9,593,246.29
  固定资产和投资性房地产折旧-63,132,830.2-25,541,006.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-63,132,830.2-25,541,006.04
  无形资产摊销-1,112,863.26-554,391.84
  长期待摊费用摊销-1,020,612.94-353,985.22
  处置固定资产、无形资产和其他长期资产的损失--44,975.63-333,569.04
  固定资产报废损失-426,420.48--
  公允价值变动损失--2,360,210.85--
  财务费用-26,139,406.12-4,142,590.48
  投资损失--3,821,335.22--1,069,991.04
  递延所得税--7,927,856.85--2,213,818.1
  其中:递延所得税资产减少--7,927,856.85--2,213,818.1
    递延所得税负债增加---0
  存货的减少-10,509,555.31-13,423,914.91
  经营性应收项目的减少-27,877,888.39-19,042,589.92
  经营性应付项目的增加--10,979,555.71--15,779,950.85
  其他-730,231.08--
  不涉及现金收支的投资和筹资活动金额其他项目-2,037,275.84--
  现金的期末余额-2,549,940,055.22-2,504,941,592.5
  减:现金的期初余额-2,783,176,213.26-2,783,176,213.26
  现金及现金等价物的净增加额--233,236,158.04--278,234,620.76
公告日期2026-04-302026-04-242025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑